Welcome to PPTA

The Plasma Protein Therapeutics Association (PPTA) is the primary advocate for the world’s leading source plasma collectors and producers of plasma-based and recombinant biological therapeutics.

The medicines produced by PPTA members are used in treating life-threatening diseases and serious medical conditions including bleeding disorders, immune system deficiencies, alpha-1 antitrypsin deficiency, burns and shock.

As the global representative for the plasma collection and therapeutics industry, PPTA works cooperatively with patient groups, policymakers, regulatory agencies and other stakeholders to address critical issues.

en Español

 

NEW! Becoming a Plasma Donor [Watch video]

Learn About Becoming a Plasma Donor

PPTA Letter to Stakeholders re: North America Data Program (February 3, 2012)
PPTA is pleased to announce that reporting of data on the U.S. supply of certain plasma protein therapies has resumed.   Read More
PPTA Letter to Stakeholders re: North America Data Program (Nov 15, 2011)
PPTA is implementing modifications to the data program, the most notable of which is the move from a one-month reporting lag to a three-month reporting lag. Product supply data reported by participating manufacturers in October 2011 will be reported on PPTA’s Web site in early February 2012. This change is effective immediately. PPTA’s commitment to shortage preparedness-related supply data reporting remains firm. We believe these changes will make the North America data program even stronger and more useful to stakeholders.  Read More
California State Assemblymember Atkins Honored At PPTA's Business Forum
ANNAPOLIS, MD (October 27, 2011) The Plasma Protein Therapeutics Association (PPTA) honored California State Assemblymember Toni Atkins (D) of San Diego as State Legislator of the Year for 2011-2012. Assemblymember Atkins received the award at the 2011 PPTA Source Business Forum taking place earlier this week in San Diego, California.  Read More